Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol vs etomidate on cerebral blood flow during anesthesia induction in elderly GI surgery patients
ChiCTR2600120207Phase 4Recruiting
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in brain ischemia, hypotension and bradyarrhythmia (3 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoints: Peak systolic blood flow velocity (Vs), Pulsatility index (PI) and 2 more. Started Mar 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
brain ischemiahypotensionbradyarrhythmia
Beyond the preview
Go deeper on ChiCTR2600120207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120207.